Joseph A. Yanchik III, Venture Partner at Apple Tree Partners, Cambridge, Massachusetts. See sector focus and contact routes.
Joseph A. Yanchik III serves as a Venture Partner at Apple Tree Partners, where he leverages over 20 years of experience founding and funding life science companies, including roles as Co-Founder and CEO of Aileron Therapeutics and Tokai Pharmaceuticals. His investment thesis centers on early-stage life sciences and biopharmaceutical enterprises, specifically targeting sectors like biotechnology, pharmaceuticals, and therapeutics within the Greater Boston area and beyond. Yanchik typically participates in investment rounds ranging from $100,000 to $5.0 million, with a sweet spot around $1.5 million, often joining Series A and B rounds. Notable portfolio companies he has supported include Red Queen Therapeutics, Marengo Therapeutics, Replicate Bioscience, and Aulos Bioscience, all of which secured significant Series A or B funding under his involvement. He also has a history of guiding companies through IPOs and major partnerships, such as Aileron Therapeutics’ 2017 IPO and its $1.1 billion deal with Roche Pharmaceuticals. While no public writing or distinctive point of view is explicitly documented in available sources, his operational background in drug developme
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Cambridge.
Investors like Joseph A. Yanchik III · Full investor directory · Investor access · Company funding database